| 75.45 Data as of May 22 |  -0.64 / -0.84%Today’s Change | 44.19 Today|||52-Week Range 78.36 | +30.60% Year-to-Date |
| ABCO Posts Solid 4Q and FY2013 Earnings - Analyst Blog May 13 / Zacks.com |
| Previous close | 76.09 |
| Today’s open | 76.08 |
| Day’s range | -- - -- |
| Volume | 349,706 |
| Average volume (3 months) | 387,916 |
| Market cap | $4.2B |
| Dividend yield | -- |
| Earnings growth (last year) | -22.22% |
| Earnings growth (this year) | +16.00% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +5.78% |
| P/E ratio | 39.1 |
| Price/Sales | 1.34 |
| Price/Book | 3.17 |
| Today’s change | Today’s % change | |
|---|---|---|
| CLDXCelldex Therapeutics... | -0.08 | -0.63% |
| MGMistras Group Inc | -0.08 | -0.38% |
| NEONeogenomics Inc | +0.16 | +4.52% |
| FCSCFibrocell Science In... | -- | -- |
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | $0.77 |
| Annual revenue (last year) | $2.4B |
| Annual profit (last year) | $94.7M |
| Net profit margin | 4.00% |
Sector Health Services |
Industry Services to the Health Industry |
Chairman & Chief Executive Officer Joseph L. Herring |
Chief Financial Officer & Vice President Alison A. Cornell, MBA |
Corporate headquarters Princeton, New Jersey |
.
